Clinical efficacy of Endostar continuous infusion combined with concurrent chemoradiotherapy in the treatment of oesophageal squamous cell carcinoma
Concurrent chemotherapy based on endostatin is effective and safe in the treatment of OSCC. Continuous 3-day Endostar infusion treatment can significantly enhance both short-and long-term therapy efficacy in patients while maintaining a high level of safety.
Authors
- Jie Wei (ORCID: https://orcid.org/0000-0003-0612-8606)
- Xinglong Du
- Wei Qin (ORCID: https://orcid.org/0000-0001-7507-1637)
- Yuting Ji (ORCID: https://orcid.org/0009-0005-1466-1920)
Institutions
- Anhui Medical University (CN)
- Chuzhou University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-10-23
- DOI
- https://doi.org/10.3389/fmed.2024.1463041
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Anhui Medical University